Replies to post #109362 on Amarantus Bioscience Holdings Inc (AMBS)

[brharris]

First ODD filed, another on the way shortly:

MANF Orphan drug designation applications filed and approved for both ocular ischemic syndrome (OIA) and Retinitis pigmentosa - completion date 12/31/14